Many emerging biopharmaceutical companies hire contract research organizations (CROs) because of limited staffing and regulatory experience to help them navigate the regulatory pathway. CROs are instrumental in helping these biopharma overcome obstacles such as clinical trial timeline delays, out-of-scope change orders and cost overruns, especially for smaller biotech companies who cannot afford drastic missteps.

All of the above highlight the need to find a CRO that will be the right fit and consistently responsive to clients’ needs.

To propel the biotech companies we partner with, TD2 utilizes a “value-add” approach, where we strive to supplement their capabilities while filling in the gaps in the internal infrastructure to help develop their plan and process every step of the way.

Hear from TD2 president and CEO, Stephen Gately, and chief operating officer, Tara Frank, about how TD2 uses their suite of capabilities to maximize the CRO and emerging biopharma relationship in this recent Applied Clinical Trials article.

Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials

Oncology clinical trials are at the forefront of medical research, paving the way for innovative treatments and advancements in the fight against...

Read more +

The Significance of Preclinical Evaluation in CAR T-cell Therapy for Solid and Hematologic Tumors

Cell therapy has emerged as a promising approach in the field of cancer treatment, and chimeric antigen receptor (CAR) T-cell therapy has shown...

Read more +

Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology

The dynamic field of cancer research is continually evolving, driven by the pursuit of deeper understanding and novel therapeutic strategies against...

Read more +


Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.

Skip to content